{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-003608","form_type":"8-K","ticker":"CPMD","cik":"0001081938","company_name":"CANNAPHARMARX, INC.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.884818+00:00","generated_at":"2026-05-24T01:26:48.924956+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CannaPharmaRX appoints Constantine Nkafu as interim CEO, adds two directors","bullets":["Constantine Nkafu appointed interim CEO and board member; has led operations for past several months.","Elliot Zemel appointed to board; holds Health Canada authorization for director role.","Adam Mindle was previously designated but decided not to pursue Health Canada approval, never became director.","Board now consists of Richard Orman, Dominic Colvin, Anthony Michael Panek, Nkafu, and Zemel.","Nkafu receives $97,000 annual salary through subsidiary employment agreement with 2323414 Alberta Ltd."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-003608","json":"https://secwatch.observer/filing/0001654954-25-003608.json","markdown":"https://secwatch.observer/filing/0001654954-25-003608.md","text":"https://secwatch.observer/filing/0001654954-25-003608.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/0001654954-25-003608-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/canna_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:26:48.924956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9de97f8765","claim":"Constantine Nkafu was appointed as Interim Chief Executive Officer at CANNAPHARMARX, INC..","evidence_excerpt":"The Board appointed Constantine Nkafu to serve as the Company’s interim CEO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/0001654954-25-003608-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b6e5ec6fbf","claim":"Elliot Zemel was appointed as Director at CANNAPHARMARX, INC..","evidence_excerpt":"Messrs. Constantine Nkafu, Company’s interim CEO, and Elliot Zemel, have now been appointed to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/0001654954-25-003608-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"de66d82adc","claim":"Constantine Nkafu was appointed as Director at CANNAPHARMARX, INC..","evidence_excerpt":"Mr. Nkafu was also appointed to the Company’s Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000165495425003608/0001654954-25-003608-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}